IRVINE, Calif. --SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to medical corporations and their clinics, today announced that Shonan Beauty Clinic, which the Company supports, has received the “JALUPRO PREMIUM AWARD” from Professional Derma SA, an Italy-based pharmaceutical and medical device manufacturer, for its “JALUPRO®” series of injectable products.
The award is presented to medical institutions that have contributed to the clinical application and widespread use of JALUPRO® products. Shonan Beauty Clinic was selected for this honor in recognition of its track record in introducing the skin quality improvement treatment “Jalupro Super Hydro,” as well as its nationwide system for safe treatment delivery and continuous accumulation of clinical cases.
JALUPRO® is an injectable product developed by Professional Derma SA, featuring a formulation that combines hyaluronic acid with an amino acid complex. Unlike injection treatments aimed solely at volume replenishment, it is widely used, particularly in Europe, as a treatment aiming to improve skin quality itself, including firmness, elasticity, texture, and radiance.
About “Jalupro Super Hydro” at Shonan Beauty Clinic
“Jalupro Super Hydro,” offered at Shonan Beauty Clinic, is an injectable formulated to aim for even higher water retention and skin quality improvement within the JALUPRO® series. By combining hyaluronic acid, amino acids, and peptides, it strengthens the ligaments that support the skin and fat from within, while providing moisture. It approaches various skin concerns associated with aging and lifestyle changes, such as fine lines, dryness, sagging, and lack of firmness or elasticity. Since it emphasizes a natural finish, it is suitable for those who desire natural skin improvement without seeking excessive changes. At Shonan Beauty Clinic, treatments are performed under the diagnosis and management of physicians, tailored to each client's skin condition.
Comment from Dr. Ayaka Nishikawa
In the field of aesthetic dermatology, including injection treatments, ensuring safety and reproducibility is of utmost importance. At Shonan Beauty Clinic, we have been committed to providing high-quality medical care through treatment design based on a thorough understanding of product characteristics, physician education, and the accumulation of case studies. We are honored to receive the JALUPRO PREMIUM AWARD, and we view this as a result of our daily efforts being recognized. We will continue to provide treatments that are close to each client while valuing medical correctness.
About Professional Derma SA
Based in Lugano, Switzerland, Professional Derma SA is a medical product manufacturer conducting research, development, and manufacturing of medical products and related items, focusing on dermatology and aesthetic medicine. With a strength in product development based on scientific evidence, they provide solutions that support skin health and natural beauty. Their flagship brand, the JALUPRO® series, is adopted by medical institutions worldwide as an injectable characterizing a combination of hyaluronic acid and amino acids, and is widely utilized in the field of aesthetic medicine.
About SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated is a comprehensive medical group operating a wide range of franchise businesses across diverse medical fields, including advanced aesthetic medicine, dermatology, orthopedics, fertility treatment, dentistry, AGA (hair restoration), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.
For more information, visit https://sbc-holdings.com/
For more insights and updates from SBC Holdings, follow us on LinkedIn
Contacts
SBC Medical Group Holdings Incorporated
Hikaru Fukui / Head of IR Department E-mail: ir@sbc-holdings.com
ICR LLC (US Time)
Bill Zima / Managing Partner E-mail: bill.zima@icrinc.com